Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Concurrent measurement of microbiome and allergens in the air of bedrooms of allergy disease patients in the Chicago area.

Richardson M, Gottel N, Gilbert JA, Gordon J, Gandhi P, Reboulet R, Hampton-Marcell JT.

Microbiome. 2019 Jun 3;7(1):82. doi: 10.1186/s40168-019-0695-5.

2.

Bedroom exposure to airborne allergens in the Chicago area using a patient-operated sampling device.

Gordon J, Detjen P, Nimmagadda S, Rogers L, Patel S, Thompson J, Reboulet R, Gandhi P.

Ann Allergy Asthma Immunol. 2018 Aug;121(2):211-217.e3. doi: 10.1016/j.anai.2018.05.024. Epub 2018 Jun 1.

PMID:
29860049
3.

Validation of a novel sampling technology for airborne allergens in low-income urban homes.

Gordon J, Reboulet R, Gandhi P, Matsui E.

Ann Allergy Asthma Immunol. 2018 Jan;120(1):96-97.e1. doi: 10.1016/j.anai.2017.10.002. No abstract available.

4.

STING-mediated DNA sensing promotes antitumor and autoimmune responses to dying cells.

Klarquist J, Hennies CM, Lehn MA, Reboulet RA, Feau S, Janssen EM.

J Immunol. 2014 Dec 15;193(12):6124-34. doi: 10.4049/jimmunol.1401869. Epub 2014 Nov 10.

5.

A peptide-free, liposome-based oligosaccharide vaccine, adjuvanted with a natural killer T cell antigen, generates robust antibody responses in vivo.

Deng S, Bai L, Reboulet R, Matthew R, Engler DA, Teyton L, Bendelac A, Savage PB.

Chem Sci. 2014 Apr;5(4):1437-1441.

6.

Natural killer T (NKT)-B-cell interactions promote prolonged antibody responses and long-term memory to pneumococcal capsular polysaccharides.

Bai L, Deng S, Reboulet R, Mathew R, Teyton L, Savage PB, Bendelac A.

Proc Natl Acad Sci U S A. 2013 Oct 1;110(40):16097-102. doi: 10.1073/pnas.1303218110. Epub 2013 Sep 16.

7.

Distinct APCs explain the cytokine bias of α-galactosylceramide variants in vivo.

Bai L, Constantinides MG, Thomas SY, Reboulet R, Meng F, Koentgen F, Teyton L, Savage PB, Bendelac A.

J Immunol. 2012 Apr 1;188(7):3053-61. doi: 10.4049/jimmunol.1102414. Epub 2012 Mar 5.

8.

Selective expansion of merocytic dendritic cells and CD8DCs confers anti-tumour effect of Fms-like tyrosine kinase 3-ligand treatment in vivo.

Hennies CM, Reboulet RA, Garcia Z, Nierkens S, Wolkers MC, Janssen EM.

Clin Exp Immunol. 2011 Mar;163(3):381-91. doi: 10.1111/j.1365-2249.2010.04305.x. Epub 2011 Jan 14.

9.

Prolonged antigen storage endows merocytic dendritic cells with enhanced capacity to prime anti-tumor responses in tumor-bearing mice.

Reboulet RA, Hennies CM, Garcia Z, Nierkens S, Janssen EM.

J Immunol. 2010 Sep 15;185(6):3337-47. doi: 10.4049/jimmunol.1001619. Epub 2010 Aug 18.

10.

Distinct roles of cytolytic effector molecules for antigen-restricted killing by CTL in vivo.

Janssen EM, Lemmens EE, Gour N, Reboulet RA, Green DR, Schoenberger SP, Pinkoski MJ.

Immunol Cell Biol. 2010 Oct;88(7):761-5. doi: 10.1038/icb.2010.37. Epub 2010 Mar 23.

11.

Dependence of reversibility and progression of mouse neuronopathic Gaucher disease on acid beta-glucosidase residual activity levels.

Xu YH, Reboulet R, Quinn B, Huelsken J, Witte D, Grabowski GA.

Mol Genet Metab. 2008 Jun;94(2):190-203. doi: 10.1016/j.ymgme.2008.01.013. Epub 2008 Mar 17.

Supplemental Content

Loading ...
Support Center